26 this month. I’m going to call out paper #3 because I think it’s super important. 1) High buprenorphine-related mortality is persistent in Finland. Kriikku P, Häkkinen M, Ojanperä I. Forensic Sci Int. 2018 Aug 17;291:76-82. doi: 10.1016/j.forsciint.2018.08.010. [Epub ahead of print] Comments: This is an interesting topic. Finland seems to have a lot ofRead More
PubMed Update July 2018
37 papers for July. Ok – now I’m up to date! 1)Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study. Larney S, Hickman M, Fiellin DA, Dobbins T, Nielsen S, Jones NR, Mattick RP, Ali R, Degenhardt L. BMJ Open.Read More
PubMed Update December 2017 – January 2018
57 for the past two months, from new ways to look at medical examiner data to an unfortunate complication of resuscitation. The fentanyl papers are at the end, as are a couple papers each addressing safe consumption spaces and opioid reformulations. 1) Wearable Biosensors to Evaluate Recurrent Opioid Toxicity After Naloxone Administration: A Hilbert Transform Approach.Read More
PubMed Update October/November 2016
43 papers this round, and there are some goodies in here for sure (don’t miss #38!). Given the number and varied issues addressed, I divided them up into topic areas and, given the number on naloxone, I divided up the naloxone topic areas as well. Naloxone interventions Primary care 1) Co-prescription of naloxone as aRead More
PubMed Update July 2016
11 papers this month, including an announcement that naloxone is now over-the-counter in Australia. 1) Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically. Evans TI, Hadland SE, Clark MA, Green TC, Marshall BD. Harm Reduct J. 2016 Jul 26;13(1):24. doi: 10.1186/s12954-016-0113-2. Comments: Less than half knewRead More
PubMed Update April 2016
23 for this month! Lots of interesting stuff, from large-scale epidemiology to randomized controlled trials. 1) Pharmacokinetic Properties and Human Use Characteristics of an FDA Approved IntranasalNaloxone Product for the Treatment of Opioid Overdose. Krieter P, Chiang N, Gyaw S, Skolnick P, Crystal R, Keegan F, Aker J, Beck M, Harris J. J Clin Pharmacol. 2016 MayRead More
PubMed Update March 2016
23 this month. 1) Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. McDonald R, Strang J. Addiction. 2016 Mar 30. doi: 10.1111/add.13326. [Epub ahead of print] Review. Comments: Take-home naloxone meets all Bradford Hill criteria for causality in reducing opioid overdose mortality. Incidence of fatality among overdoses in the setting ofRead More
PubMed Update February 2016
Ten articles for February 2016. 1) As opioid overdose deaths reach record highs, call for systematic changes grows louder. [No authors listed] ED Manag. 2016 Feb;28(2):13-9. Comments: Review of the new CDC opioid prescribing guidelines. 2) Australia reschedules naloxone for opioid overdose. Lenton SR, Dietze PM, Jauncey M. Med J Aust. 2016 Mar 7;204(4):146-7. No abstract available. Comments: Naloxone canRead More
PubMed Update June – July 2015
Great stuff this time! 34 in two months. Opioid OverdosePrevention Programs Providing Naloxoneto Laypersons – United States, 2014. Wheeler E, Jones TS, Gilbert MK, Davidson PJ. MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):631-5. Comment: The long-awaited sequel to 2010’s blockbuster naloxone MMWR report! 152,283 laypersons trained and 26,463 overdose reversals reported to naloxone programs through 2014.Read More
PubMed Update August-October 2014
Three months. 32 articles. Enough said. Patterns and correlates of non-fatal heroin overdose at 11-year follow-up: Findings from the Australian Treatment Outcome Study. Darke S, Marel C, Mills KL, Ross J, Slade T, Burns L, Teesson M. Drug Alcohol Depend. 2014 Sep 16. [Epub ahead of print] Comment: This study (the ATOS) and the teamRead More